Response to radiotherapy of human uterine cervix carcinoma is not correlated with rearrangements of the Ha-ras-1 and/or c-myc genes

European Journal of Cancer Part A

Volumn 33, Issue 6, 1997, Pages 942-949

  Polischouk, A G ^a   Scotnikova, O I ^b   Sergeeva, N S ^b   Zharinov, G M ^c   Lewensohn, R ^a   Zhivotovsky, B ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b P A Herzen Research Oncological Institute   (Russian Federation)

^c Russian Center for Research in Radiological and Surgical Technologies   (Russian Federation)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

C myc genes; Cervical carcinomas; Ha ras 1; Radiosensitivity

Indexed keywords

ALLELE; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; EXON; FEMALE; GENE ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C MYC; ONCOGENE H RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOSENSITIVITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; UTERINE CERVIX CARCINOMA;

ALLELES; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE REARRANGEMENT; GENES, MYC; GENES, RAS; HUMANS; POLYMERASE CHAIN REACTION; RADIATION TOLERANCE; SUBRENAL CAPSULE ASSAY; UTERINE CERVICAL NEOPLASMS;

EID: 0030836807     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00024-5     Document Type: Article

References (33)

1. FitzGerald TJ, Daugherty C, Kase K, Rothstein LA, McKenna M, Greenberger JS. Activated human N-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less effectively at low dose rate. Am J Clin Oncol 1985, 8, 517-522.
2. Sklar MD. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 1988, 239, 645-647.
3. Pirollo KF, Garner R, Yuan SY, Li L, Blattner WA, Chang EH. Raf involvement in the simultaneous genetic transfer of the radioresistant and transforming phenotypes. Int J Radiat Biol 1989, 55, 783-796.
4. FitzGerald TJ, Henault S, Sakakeeny M, et al. Expression of transfected recombinant oncogenes increases radiation resistance of clonal haemopoietic and fibroblast cell lines selectively at clinical low rate. Radiat Res 1990, 122, 44-52.
5. FitzGerald TJ, Santucci MA, Das I, Kase K, Pierce JH, Greenberger JS. The v-abl, c-fms, or v-myc oncogene induces gamma radiation resistance of haematopoietic progenitor cell line 32D cl 3 at clinical low dose rate. Int J Radiat Oncol Biol Phys 1991, 21, 1203-1210.
6. McKenna WG, Weiss MC, Bakanauskas VJ, et al. The role of the H-ras oncogene in radiation resistance and metastasis. Int J Radiat Oncol Biol Phys 1990, 18, 849-859.
7. Suzuki K, Watanabe M, Miyoshi J. Differences in effects of oncogenes on resistance to γ rays, ultraviolet light and heat shock. Radiat Res 1992, 129, 157-162.
8. Russell J, Khan MZ, Kerr DJ, Spandidos DA. The effect of transfection with the oncogenes H-ras and c-myc on the radiosensitivity of a mink epithelial cell line. Radiat Res 1992, 130, 113-116.
9. Chang EH, Pirollo KF, Zou ZQ, et al. Oncogenes in radioresistant, noncancerous skin fibroblasts from a cancer-prone family. Science 1987, 237, 1036-1039.
10. Kasid UN, Pfeifer A, Brennan T, et al. Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science 1989, 243, 1354-1356.
11. Mendonca MS, Boukamp P, Stanbridge EJ, Redpath JL. The radiosensitivity of human keratinocytes: influence of activated c-H-ras oncogene expression and tumorigenicity. Int J Radiat Biol 1991, 59, 1195-1206.
12. Grant ML, Bruton RK, Byrd PJ, et al. Sensitivity to ionising radiation of transformed human cells containing mutant ras genes. Oncogene 1990, 5, 1159-1164.
13. Su L-N, Little JB. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or Simian Virus 40 T-antigen. Radiat Res 1993, 133, 73-79.
14. Alapetite C, Baroche C, Remvikos Y, Goubin G, Moustacchi E. Studies on the influence of the presence of an activated ras oncogene on the in vitro radiosensitivity of human mammary epithelial cells. Int J Radiat Biol 1991, 59, 385-396.
15. Little CD, Nau MM, Carney DN, Bazdar AF, Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 1983, 306, 194-196.
16. Rygaard K, Slebos RJC, Spang-Thomsen M. Radiosensitivity of small-cell lung cancer xenographs compared with activity of c-myc, N-myc, c-raf-1 and K-ras protooncogenes. Int J Cancer 1991, 49, 279-284.
17. Warenius HM, Browning PGW, Britten RA, Peacock JA, Rapp UR. c-raf-1 protooncogene expression relates to radiosensitivity rather than radioresistance. Eur J Cancer 1994, 30A, 369-375.
18. Capon DJ, Seeburg PH, McGrath JP, et al. Activation of Ki-ras 2 gene in human colon and lung carcinomas by two different point mutations. Nature 1983, 309, 507-513.
19. Riou G, Barrois M, Sheng Z-M, Duvillard P, Lhomme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 1988, 3, 329-333.
20. Atassi G, Dumont P, Fournier J. New methods for determining tumour sensitivity. Eur J Cancer Clin Oncol 1985, 11, 1299-1301.
21. Scotnikova OI, Sergeeva NS, Sviridova IK, et al. The growth parameters of lung cancer transplants in subrenal capsule assay. Exp Oncol 1990, 12, 41-43.
22. Shih C, Weinberg RA. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 1982, 29, 161-169.
23. Nishikura K, ar-Rushdi A, Erikson J, Watt R, Rovera G, Croce CM. Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. Proc Natl Acad Sci USA 1983, 80, 4822-4826.
24. Field JK, Spandidos DA. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis. Anticancer Res 1990, 10, 1-22.
25. Levine EL, Davidson SE, Roberts SA, Chadwick CA, Potten CS, West CML. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet 1994, 344, 472.
26. Schwarts JL, Mustafi R, Beckett MA, et al. Radiation-induced DNA double-strand break frequencies in human squamous cell carcinoma cell lines of different radiation sensitivities. Int J Radiat Biol 1991, 59, 1341-1352.
27. McMillan TJ, Cassoni AM, Edwards S, Holmes A, Peacock JH. The relationship of DNA double-strand break induction to radiosensitivity in human tumour cell lines. Int J Radiat Biol 1990, 58, 427-438.
28. Anderson CW. DNA damage and the DNA activated protein kinase. Trends Biochem Sci 1993, 18, 433-437.
29. Weaver DT. What to do at an end: DNA double-strand-break repair. Trends Genet 1995, 11, 388-392.
30. Jackson SP, Jeggo PA. DNA double-strand break repair and V(D)J recombination: involvement of DNA-PK. Trends Biochem Sci 1995, 20, 412-415.
31. Fiscella M, Ullrich SJ, Zambrano N, et al. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 1993, 8, 1519-1528.
32. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74, 957-967.
33. Ryan JJ, Prochownik E, Gottlieb CA, et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994, 91, 5878-5882.